Approval · Notice of Compliance 11591 · 2010
CO FINASTERIDE: Notice of Compliance 11591
Issued July 16, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11591
- Date
- July 16, 2010
- Company
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Type II 5-alpha-reductase inhibitor
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CO FINASTERIDE | 02354462 | Cancelled Post Market |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB